iShares U.S. Pharmaceuticals ETF (IHE) |
| 94.75 -0.32 (-0.34%) 06-12 16:00 |
| Open: | 95.46 |
| High: | 95.53 |
| Low: | 94.665 |
| Volume: | 44,025 |
| Market Cap: | 735(M) |
| PE Ratio: | 26.54 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 111.73 |
| Resistance 1: | 95.65 |
| Pivot price: | 92.19 |
| Support 1: | 90.24 |
| Support 2: | 86.90 |
| 52w High: | 95.6 |
| 52w Low: | 64.46 |
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 11 Jun 2026
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year - NAI500
Wed, 10 Jun 2026
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
Wed, 10 Jun 2026
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
Wed, 27 May 2026
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - AOL.com
Wed, 27 May 2026
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - The Motley Fool
Sun, 24 May 2026
Precision Trading with Ishares U.s. Pharmaceuticals Etf (IHE) Risk Zones - Stock Traders Daily
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
